A

Incorporating Pathomics Into IgAN Risk Prediction

Kidney International Reports, vol. 11, pp. 106708

Abstract

Introduction: IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide, with heterogeneous progression rates. The International IgAN Prediction Tool (IIgAN-PT) enables individualized risk prediction using clinical characteristics and histopathological scoring. However, traditional histopathological scoring is semiquantitative and prone to interobserver variability. Deep learning-based, automated quantification of digitized histopathology enables the extraction of quantitative morphological biomarkers (pathomics). Here, we evaluated the added prognostic value of pathomics over traditional histopathology and its potential integration into the IIgAN-PT. Methods: We analyzed a multicenter European cohort of 555 adults with biopsy-proven IgAN (VALIGA), including centralized histopathology assessment. We assessed the potential of 25 clinically interpretable candidate pathomics predictors across 2 clinically relevant settings by (i) comparing pathomics with traditional histopathology (MEST-C [mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental glomerulosclerosis (S), tubular atrophy and/or interstitial fibrosis (T) and crescents (C)]) and (ii) extending the IIgAN-PT with pathomics. Model performance was evaluated by overall fit, discrimination, reclassification, and calibration. Results: In a direct comparison, pathomics slightly outperformed the MEST-C score when used alone (Δ C-statistic 0.04 (95% confidence interval [CI]: 0.03-0.06)) but was marginally worse after adjusting for clinical predictors (Δ C-statistic -0.034 [95% CI: -0.042 to -0.027]). Patient stratification into clinical risk groups was consistent between models. Combining pathomics and traditional histopathology led to minor improvements over the current IIgAN-PT (without ethnicity, Δ C-statistic 0.024 [95% CI: 0.019-0.028]). Pathomics variables captured chronic morphological changes including glomerular deformation, tubular shrinkage, and arterial luminal narrowing. Conclusion: Our findings indicate that pathomics-derived digital tissue biomarkers provide an additional layer of information and are noninferior to MEST-C, supporting more standardized, robust, and reproducible risk stratification in IgAN.

Authors 100

  1. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    Department of Nephrology and Immunology, RWTH Aachen University Hospital, Aachen, Germany

    Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany

  2. Sean J. Barbour corresponding

    University of British Columbia · BC Renal

    Affiliation as printed

    BC Renal, Vancouver, Canada

    Division of Nephrology, University of British Columbia, Vancouver, Canada

  3. Fondazione Ricerca Molinette · Ospedale Regina Margherita

    Affiliation as printed

    Fondazione Ricerca Molinette, Torino, Italy

    Regina Margherita Children's University Hospital, Torino, Italy

  4. University of British Columbia

    Affiliation as printed

    Division of Nephrology, University of British Columbia, Vancouver, Canada

  5. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany

  6. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany

  7. Charles University · General University Hospital in Prague

    Affiliation as printed

    Department of Nephrology, 1 Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic

  8. National Health Service · University of Leicester · University Hospitals of Leicester NHS Trust

    Affiliation as printed

    Department of Cardiovascular Sciences, University of Leicester, Leicester, UK

    John Walls Renal Unit, University Hospital of Leicester National Health Service Trust, Leicester, UK

  9. Affiliation as printed

    Department of Cellular Pathology, Oxford University Hospitals National Health Services Foundation Trust, Oxford, UK

  10. Peter Boor corresponding Aachen Institute of Pathology

    Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany

  11. Affiliation as printed

    Department of Cellular Pathology, Oxford University Hospitals National Health Services Foundation Trust, Oxford, UK

  12. Charles University · General University Hospital in Prague

    Affiliation as printed

    Department of Nephrology, 1 Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-06).

References 30